Inventor · disambiguated record
Philip Pye
Also filed as: PYE PHILIP · PYE PHILIP J · PYE PHILIP JAMES
26 granted patents·8 pending applications·283 citations·filing 1997–2024
96Inventor score
Top patents by PatentIndex Score
34 records- 0191US8569494B2Methods of synthesis and purification of heteroaryl compoundsHARRIS ROY L·Filed 2010·Granted Oct 29, 2013·27 cites·23 claims
- 0290US9156847B2Processes and intermediates for preparing a medicamentJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 13, 2015·8 cites·16 claims
- 0389US6369275B1Process for making diaryl pyridines useful as cox-2 inhibitorsMERCK & CO INC·Filed 2000·Granted Apr 9, 2002·18 cites·6 claims
- 0489US6040450AProcess for making diaryl pyridines useful as cox-2-inhibitorsMERCK & CO INC·Filed 1998·Granted Mar 21, 2000·43 cites·19 claims
- 0588US2025197404A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 0687US6204387B1Process for making diaryl pyridines useful as COX-2 inhibitorsMERCK & CO INC·Filed 1998·Granted Mar 20, 2001·33 cites·7 claims
- 0785US8686135B2Methods of synthesis and purification of heteroaryl compoundsSIGNAL PHARM LLC·Filed 2013·Granted Apr 1, 2014·8 cites·21 claims
- 0884US9079900B2Methods of synthesis and purification of heteroaryl compoundsSIGNAL PHARM LLC·Filed 2014·Granted Jul 14, 2015·5 cites·27 claims
- 0984US2024158400A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 1082US6127545AProcess for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitorsMERCK & CO INC·Filed 1998·Granted Oct 3, 2000·30 cites·19 claims
- 1180US7598264B2HIV integrase inhibitorsMERCK & CO INC·Filed 2005·Granted Oct 6, 2009·7 cites·11 claims
- 1280US6252116B1Intermediates useful in a process for synthesizing COX-2 inhibitorsMERCK & CO INC·Filed 2000·Granted Jun 26, 2001·13 cites·6 claims
- 1377US6040319AProcess for synthesizing COX-2 inhibitorsMERCK & CO INC·Filed 1999·Granted Mar 21, 2000·36 cites·21 claims
- 1474US10138246B2Deuterated triazolopyridazine as a kinase modulatorJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Nov 27, 2018·2 cites·17 claims
- 1573US2022098200A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 1672US6914144B2Process for preparing integrin antagonist intermediateMERCK & CO INC·Filed 2003·Granted Jul 5, 2005·5 cites·13 claims
- 1772US6130334AProcess for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitorsMERCK & CO INC·Filed 1998·Granted Oct 10, 2000·25 cites·2 claims
- 1872US2020347064A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1969US5874629AChiral bisphosphinesMERCK & CO INC·Filed 1997·Granted Feb 23, 1999·11 cites·6 claims
- 2068US2019367518A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2167US6538134B24-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereofMERCK & CO INC·Filed 2001·Granted Mar 25, 2003·3 cites·14 claims
- 2266US8357798B2Process for preparing N-alkylated hydroxypyrimidinone compoundsMERCK SHARP & DOHME·Filed 2010·Granted Jan 22, 2013·1 cites·14 claims
- 2361US2018009814A1Synthesis of a bruton?s tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2459US6469164B2Process for the synthesis of (2R, 2-alpha-R)-4-benzyl-2-[1-(3,5-bis (trifluoromethyl)phenyl)ethoxy]-1,4-oxazine-3-oneMERCK & CO INC·Filed 2001·Granted Oct 22, 2002·1 cites·8 claims
- 2557US2024279227A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2022·Application pending·0 cites
- 2655US10464939B2Deuterated triazolopyridazine as a kinase modulatorJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Nov 5, 2019·0 cites·2 claims
- 2753US6043387AChiral bisphosphinesMERCK & CO INC·Filed 1999·Granted Mar 28, 2000·4 cites·11 claims
- 2849US12459948B2Processes and intermediates for preparing a Btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 4, 2025·0 cites·9 claims
- 2948US2015376193A1Processes and intermediates for preparing a medicamentJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3047US12215110B2Processes and intermediates for preparing a Btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 4, 2025·0 cites·22 claims
- 3143US6395894B2Process for the synthesis of carbapenem intermidiates, and compounds producedFiled 1999·Granted May 28, 2002·2 cites·29 claims
- 3241US6156895AProcess for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamideMERCK & CO INC·Filed 1999·Granted Dec 5, 2000·1 cites·5 claims
- 3340US6403793B2Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5- bis (trifluoromethyl) phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazineMERCK & CO INC·Filed 2001·Granted Jun 11, 2002·0 cites·8 claims
- 3435US5977364AProcess for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamideMERCK & CO INC·Filed 1999·Granted Nov 2, 1999·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Philip Pye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →